1. Home
  2. Browse Decisions
  3. S.Ct.
  4. 131 S.Ct.
  5. 131 S.Ct. 1342 (2011)
 

ASTRA USA, INC. v. SANTA CLARA COUNTY, CAL.

No. 09-1273.

131 S.Ct. 1342 (2011)

563 U.S. 110

ASTRA USA, INC., et al., Petitioners, v. SANTA CLARA COUNTY, CALIFORNIA

Supreme Court of United States.

Decided March 29, 2011.

Attorney(s) appearing for the Case

Lisa S. Blatt , Washington, DC, for petitioners.

Ginger D. Anders , for United States, as amicus curiae, by special leave of the Court, supporting the petitioners.

David C. Frederick , Washington, DC, for the respondent.

Miguel Marquez , County Counsel, Greta S. Hansen , Juniper L. Downs , James R. Wilhams , Office of the County Counsel, County of Santa Clara, San Jose, California, Sanford Svetcov, Jeffrey W. Lawrence , Susan K. Alexander , Aelish M. Baig , Robbins Geller Rudman & Dowd LLP, San Francisco, Cahfornia, David C. Frederick , Counsel of Record, Scott H. Angstreich , Scott K. Attaway , Kellogg, Huber, Hansen, Todd, Evans & Figel, P.L.L.C., Washington, D.C., for respondent.

Lisa S. Blatt , Counsel of Record, Jeffrey L. Handwerker , Anthony J. Franze , Kristin M. Hicks , Arnold & Porter LLP, Washington, DC, for Petitioners Astra USA, Inc., AstraZeneca Pharmaceuticals LP and Zeneca Inc.

James P. Muehlberger , Robert J. McCully , Ina D. Chang , Shook, Hardy & Bacon LLP, Kansas City, MO, for Petitioners Aventis Pharmaceuticals Inc. and ZLB Behring LLC. Paul J. Riehle , Matthew A. Fischer , Sedgwick, Detert, Moran & Arnold LLP, San Francisco, CA, Lyndon M. Tretter , Jessica P. Feingold , Hogan Lovells US LLP, New York, NY, for Petitioner Bristol-Myers Squibb Company.

Richard D. Raskin , Scott D. Stem , Sidley Austin LLP, Chicago, IL, for Petitioner Bayer Corporation.

Kirke M. Hasson , Colin T. Kemp , Pillsbury Winthrop Shaw Pittman LLP, San Francisco, CA, for Petitioner Merck & Co., Inc. f/d/b/a/ Schering-Plough Corporation. Frederick G. Herold , Dechert LLP, Mountain View, CA, for Petitioner SmithKline Beecham Corporation d/b/a GlaxoSmithKline.

Brian W. Shaffer , Erica Smith-Klocek , Jennifer Jordan , Morgan, Lewis & Bockius LLP, Philadelphia, PA, R. Ted Cruz , Allyson N. Ho, Morgan , Lewis & Bockius LLP, Houston, TX, for Petitioner Pfizer Inc.

Peter N. Larson , David L. Wallach , Jones Day , San Francisco, CA, for Petitioners Tap Pharmaceutical Products Inc. n/k/a Takeda Pharmaceuticals North America, Inc.

Fletcher C. Alford , Ryan B. Polk , Gordon & Rees LLP, San Francisco, CA, S. Craig Holden , Kelly J. Davidson , Ober Kaler, Grimes & Shriver, Baltimore, MD, for Petitioners Wyeth, Inc. and Wyeth Pharmaceuticals, Inc.

Justice GINSBURG, Delivered the opinion of the Court.

Section 340B of the Public Health Services Act, 42 U.S.C.A. § 256b (Oct.2010 Supp.), imposes ceilings on prices drug manufacturers may charge for medications sold to specified health care facilities. Those facilities, here called "340B" or "covered" entities, include public hospitals and community health centers, many of them providers of safety-net services to the poor. The § 340B ceiling-price program...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases